Skip to main content
Top
Published in: Journal of Gastroenterology 2/2024

Open Access 14-11-2023 | Gastritis | Original Article—Alimentary Tract

Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation

Authors: Chihiro Takeuchi, Junichi Sato, Nobutake Yamamichi, Natsuko Kageyama-Yahara, Akiko Sasaki, Takemi Akahane, Rika Aoki, Shigemi Nakajima, Masayoshi Ito, Mitsue Yamamichi, Yu-Yu Liu, Nobuyuki Sakuma, Yu Takahashi, Yoshiki Sakaguchi, Yosuke Tsuji, Kouhei Sakurai, Shuta Tomida, Keiko Niimi, Toshikazu Ushijima, Mitsuhiro Fujishiro

Published in: Journal of Gastroenterology | Issue 2/2024

Login to get access

Abstract

Background

Autoimmune gastritis (AIG) is a prevalent chronic inflammatory disease with oncogenic potential that causes destruction of parietal cells and severe mucosal atrophy. We aimed to explore the distinctive gene expression profiles, activated signaling pathways, and their underlying mechanisms.

Methods

A comprehensive gene expression analysis was conducted using biopsy specimens from AIG, Helicobacter pylori-associated gastritis (HPG), and non-inflammatory normal stomachs. Gastric cancer cell lines were cultured under acidic (pH 6.5) conditions to evaluate changes in gene expression.

Results

Gastric mucosa with AIG had a unique gene expression profile compared with that with HPG and normal mucosa, such as extensively low expression of ATP4A and high expression of GAST and PAPPA2, which are involved in neuroendocrine tumorigenesis. Additionally, the mucosa with AIG and HPG showed the downregulation of stomach-specific genes and upregulation of small intestine-specific genes; however, intestinal trans-differentiation was much more prominent in AIG samples, likely in a CDX-dependent manner. Furthermore, AIG induced ectopic expression of pancreatic digestion-related genes, PNLIP, CEL, CTRB1, and CTRC; and a master regulator gene of the lung, NKX2-1/TTF1 with alveolar fluid secretion-related genes, SFTPB and SFTPC. Mechanistically, acidic conditions led to the downregulation of master regulator and stemness control genes of small intestine, suggesting that increased environmental pH may cause abnormal intestinal differentiation in the stomach.

Conclusions

AIG induces diverse trans-differentiation in the gastric mucosa, characterized by the transactivation of genes specific to the small intestine, pancreas, and lung. Increased environmental pH owing to AIG may cause abnormal differentiation of the gastric mucosa.
Appendix
Available only for authorised users
Literature
1.
go back to reference Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973;18:426–40.PubMedCrossRef Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973;18:426–40.PubMedCrossRef
2.
go back to reference Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–41.PubMedCrossRef Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis–pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–41.PubMedCrossRef
4.
go back to reference Itsuno M, Watanabe H, Iwafuchi M, et al. Multiple carcinoids and endocrine cell micronests in type A gastritis. Their morphology, histogenesis, and natural history. Cancer. 1989;63:881–90.PubMedCrossRef Itsuno M, Watanabe H, Iwafuchi M, et al. Multiple carcinoids and endocrine cell micronests in type A gastritis. Their morphology, histogenesis, and natural history. Cancer. 1989;63:881–90.PubMedCrossRef
5.
go back to reference Müller J, Kirchner T, Müller-Hermelink HK. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol. 1987;11:909–17.PubMedCrossRef Müller J, Kirchner T, Müller-Hermelink HK. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol. 1987;11:909–17.PubMedCrossRef
6.
go back to reference Takeuchi C, Sato J, Yamashita S, et al. Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential. J Gastroenterol. 2022;57:144–55.PubMedCrossRef Takeuchi C, Sato J, Yamashita S, et al. Autoimmune gastritis induces aberrant DNA methylation reflecting its carcinogenic potential. J Gastroenterol. 2022;57:144–55.PubMedCrossRef
7.
go back to reference Repetto O, De Re V, Giuffrida P, et al. Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer. Gastric Cancer. 2021;24:666–79.PubMedPubMedCentralCrossRef Repetto O, De Re V, Giuffrida P, et al. Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer. Gastric Cancer. 2021;24:666–79.PubMedPubMedCentralCrossRef
8.
go back to reference Yamamichi N, Hirano C, Takahashi Y, et al. Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis. Gastric Cancer. 2016;19:670–5.PubMedCrossRef Yamamichi N, Hirano C, Takahashi Y, et al. Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis. Gastric Cancer. 2016;19:670–5.PubMedCrossRef
9.
go back to reference Bateman AR, El-Hachem N, Beck AH, et al. Importance of collection in gene set enrichment analysis of drug response in cancer cell lines. Sci Rep. 2014;4:4092.PubMedPubMedCentralCrossRef Bateman AR, El-Hachem N, Beck AH, et al. Importance of collection in gene set enrichment analysis of drug response in cancer cell lines. Sci Rep. 2014;4:4092.PubMedPubMedCentralCrossRef
10.
go back to reference Jain A, Tuteja G. TissueEnrich: tissue-specific gene enrichment analysis. Bioinformatics. 2019;35:1966–7.PubMedCrossRef Jain A, Tuteja G. TissueEnrich: tissue-specific gene enrichment analysis. Bioinformatics. 2019;35:1966–7.PubMedCrossRef
11.
go back to reference Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–13.PubMedCrossRef Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–13.PubMedCrossRef
12.
go back to reference Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.PubMedCrossRef Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.PubMedCrossRef
13.
go back to reference Kamada T, Watanabe H, Furuta T, et al. Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan. J Gastroenterol. 2023;58:185–95.PubMedPubMedCentralCrossRef Kamada T, Watanabe H, Furuta T, et al. Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan. J Gastroenterol. 2023;58:185–95.PubMedPubMedCentralCrossRef
14.
go back to reference Lloyd KA, Parsons BN, Burkitt MD, et al. Netazepide inhibits expression of pappalysin 2 in Type 1 gastric neuroendocrine tumors. Cell Mol Gastroenterol Hepatol. 2020;10:113–32.PubMedPubMedCentralCrossRef Lloyd KA, Parsons BN, Burkitt MD, et al. Netazepide inhibits expression of pappalysin 2 in Type 1 gastric neuroendocrine tumors. Cell Mol Gastroenterol Hepatol. 2020;10:113–32.PubMedPubMedCentralCrossRef
15.
go back to reference Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40.PubMed Correa P. Human gastric carcinogenesis: a multistep and multifactorial process–First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40.PubMed
16.
go back to reference Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59:1003–7.PubMed Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res. 1999;59:1003–7.PubMed
17.
go back to reference Silberg DG, Swain GP, Suh ER, et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology. 2000;119:961–71.PubMedCrossRef Silberg DG, Swain GP, Suh ER, et al. Cdx1 and cdx2 expression during intestinal development. Gastroenterology. 2000;119:961–71.PubMedCrossRef
18.
go back to reference Mutoh H, Sakurai S, Satoh K, et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut. 2004;53:1416–23.PubMedPubMedCentralCrossRef Mutoh H, Sakurai S, Satoh K, et al. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut. 2004;53:1416–23.PubMedPubMedCentralCrossRef
19.
go back to reference Guo RJ, Suh ER, Lynch JP. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther. 2004;3:593–601.PubMedCrossRef Guo RJ, Suh ER, Lynch JP. The role of Cdx proteins in intestinal development and cancer. Cancer Biol Ther. 2004;3:593–601.PubMedCrossRef
20.
go back to reference Nakayama C, Yamamichi N, Tomida S, et al. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation. Cancer Sci. 2018;109:3853–64.PubMedPubMedCentralCrossRef Nakayama C, Yamamichi N, Tomida S, et al. Transduced caudal-type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX-deficient gastric cancer by rapid intestinal differentiation. Cancer Sci. 2018;109:3853–64.PubMedPubMedCentralCrossRef
21.
go back to reference Sims HF, Jennens ML, Lowe ME. The human pancreatic lipase-encoding gene: structure and conservation of an Alu sequence in the lipase gene family. Gene. 1993;131:281–5.PubMedCrossRef Sims HF, Jennens ML, Lowe ME. The human pancreatic lipase-encoding gene: structure and conservation of an Alu sequence in the lipase gene family. Gene. 1993;131:281–5.PubMedCrossRef
22.
go back to reference Wang CS, Hartsuck JA. Bile salt-activated lipase. A multiple function lipolytic enzyme. Biochim Biophys Acta. 1993;1166:1–19.PubMedCrossRef Wang CS, Hartsuck JA. Bile salt-activated lipase. A multiple function lipolytic enzyme. Biochim Biophys Acta. 1993;1166:1–19.PubMedCrossRef
23.
go back to reference Szmola R, Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht’s enzyme Y. Proc Natl Acad Sci USA. 2007;104:11227–32.PubMedPubMedCentralCrossRef Szmola R, Sahin-Tóth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht’s enzyme Y. Proc Natl Acad Sci USA. 2007;104:11227–32.PubMedPubMedCentralCrossRef
24.
go back to reference Mou H, Zhao R, Sherwood R, et al. Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell. 2012;10:385–97.PubMedPubMedCentralCrossRef Mou H, Zhao R, Sherwood R, et al. Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell. 2012;10:385–97.PubMedPubMedCentralCrossRef
25.
go back to reference Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LM, et al. Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry. 1991;30:10965–71.PubMedCrossRef Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LM, et al. Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry. 1991;30:10965–71.PubMedCrossRef
26.
go back to reference La Rosa S, Franzi F, Marchet S, et al. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch. 2009;454:133–42.PubMedCrossRef La Rosa S, Franzi F, Marchet S, et al. The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia. Virchows Arch. 2009;454:133–42.PubMedCrossRef
27.
go back to reference Jhala NC, Montemor M, Jhala D, et al. Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med. 2003;127:854–7.PubMedCrossRef Jhala NC, Montemor M, Jhala D, et al. Pancreatic acinar cell metaplasia in autoimmune gastritis. Arch Pathol Lab Med. 2003;127:854–7.PubMedCrossRef
28.
go back to reference Rugge M, Di Mario F, Cassaro M, et al. Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology. 1993;22:9–15.PubMedCrossRef Rugge M, Di Mario F, Cassaro M, et al. Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology. 1993;22:9–15.PubMedCrossRef
30.
go back to reference Larsen F, Gundersen G, Lopez R, et al. CpG islands as gene markers in the human genome. Genomics. 1992;13:1095–107.PubMedCrossRef Larsen F, Gundersen G, Lopez R, et al. CpG islands as gene markers in the human genome. Genomics. 1992;13:1095–107.PubMedCrossRef
31.
go back to reference Irie T, Yamada H, Takeuchi C, et al. The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa. Gastric Cancer. 2023. Irie T, Yamada H, Takeuchi C, et al. The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa. Gastric Cancer. 2023.
32.
go back to reference Basehoar AD, Zanton SJ, Pugh BF. Identification and distinct regulation of yeast TATA box-containing genes. Cell. 2004;116:699–709.PubMedCrossRef Basehoar AD, Zanton SJ, Pugh BF. Identification and distinct regulation of yeast TATA box-containing genes. Cell. 2004;116:699–709.PubMedCrossRef
33.
go back to reference Tenca A, Massironi S, Pugliese D, et al. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring. Neurogastroenterol Motil. 2016;28:274–80.PubMedCrossRef Tenca A, Massironi S, Pugliese D, et al. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring. Neurogastroenterol Motil. 2016;28:274–80.PubMedCrossRef
34.
go back to reference Kulnigg-Dabsch S, Resch M, Oberhuber G, et al. Iron deficiency workup reveals high incidence of autoimmune gastritis with parietal cell antibody as reliable screening test. Semin Hematol. 2018;55:256–61.PubMedCrossRef Kulnigg-Dabsch S, Resch M, Oberhuber G, et al. Iron deficiency workup reveals high incidence of autoimmune gastritis with parietal cell antibody as reliable screening test. Semin Hematol. 2018;55:256–61.PubMedCrossRef
35.
go back to reference Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–7.PubMedCrossRef Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–7.PubMedCrossRef
36.
go back to reference van der Flier LG, van Gijn ME, Hatzis P, et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell. 2009;136:903–12.PubMedCrossRef van der Flier LG, van Gijn ME, Hatzis P, et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell. 2009;136:903–12.PubMedCrossRef
37.
go back to reference van der Flier LG, Haegebarth A, Stange DE, et al. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology. 2009;137:15–7.PubMedCrossRef van der Flier LG, Haegebarth A, Stange DE, et al. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology. 2009;137:15–7.PubMedCrossRef
38.
go back to reference Arai J, Niikura R, Hayakawa Y, et al. Clinicopathological features of gastric cancer with autoimmune gastritis. Biomedicines. 2022;10. Arai J, Niikura R, Hayakawa Y, et al. Clinicopathological features of gastric cancer with autoimmune gastritis. Biomedicines. 2022;10.
39.
go back to reference Katsurano M, Niwa T, Yasui Y, et al. Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene. 2012;31:342–51.PubMedCrossRef Katsurano M, Niwa T, Yasui Y, et al. Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction. Oncogene. 2012;31:342–51.PubMedCrossRef
40.
go back to reference Niwa T, Tsukamoto T, Toyoda T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70:1430–40.PubMedCrossRef Niwa T, Tsukamoto T, Toyoda T, et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70:1430–40.PubMedCrossRef
41.
go back to reference Hur K, Niwa T, Toyoda T, et al. Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation. Carcinogenesis. 2011;32:35–41.PubMedCrossRef Hur K, Niwa T, Toyoda T, et al. Insufficient role of cell proliferation in aberrant DNA methylation induction and involvement of specific types of inflammation. Carcinogenesis. 2011;32:35–41.PubMedCrossRef
42.
go back to reference Takeshima H, Niwa T, Yamashita S, et al. TET repression and increased DNMT activity synergistically induce aberrant DNA methylation. J Clin Invest. 2020;130:5370–9.PubMedPubMedCentralCrossRef Takeshima H, Niwa T, Yamashita S, et al. TET repression and increased DNMT activity synergistically induce aberrant DNA methylation. J Clin Invest. 2020;130:5370–9.PubMedPubMedCentralCrossRef
43.
go back to reference Takeuchi C, Yamashita S, Liu YY, et al. Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. Gut. 2023. Takeuchi C, Yamashita S, Liu YY, et al. Precancerous nature of intestinal metaplasia with increased chance of conversion and accelerated DNA methylation. Gut. 2023.
44.
go back to reference Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295:683–6.PubMedCrossRef Higashi H, Tsutsumi R, Muto S, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295:683–6.PubMedCrossRef
45.
go back to reference Ohnishi N, Yuasa H, Tanaka S, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A. 2008;105:1003–8.PubMedPubMedCentralCrossRef Ohnishi N, Yuasa H, Tanaka S, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A. 2008;105:1003–8.PubMedPubMedCentralCrossRef
46.
go back to reference Yamamichi N, Inada K, Ichinose M, et al. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res. 2007;67:10727–35.PubMedCrossRef Yamamichi N, Inada K, Ichinose M, et al. Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state. Cancer Res. 2007;67:10727–35.PubMedCrossRef
47.
go back to reference Bettington M, Brown I. Autoimmune gastritis: novel clues to histological diagnosis. Pathology. 2013;45:145–9.PubMedCrossRef Bettington M, Brown I. Autoimmune gastritis: novel clues to histological diagnosis. Pathology. 2013;45:145–9.PubMedCrossRef
48.
go back to reference Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 1994;371:606–9.PubMedCrossRef Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 1994;371:606–9.PubMedCrossRef
49.
go back to reference Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32:364–72.PubMedCrossRef Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32:364–72.PubMedCrossRef
50.
go back to reference Fukagawa K, Takahashi Y, Yamamichi N, et al. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2–1/TTF-1) in gastric adenocarcinoma of fundic-gland type. Gastric Cancer. 2022. Fukagawa K, Takahashi Y, Yamamichi N, et al. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2–1/TTF-1) in gastric adenocarcinoma of fundic-gland type. Gastric Cancer. 2022.
51.
go back to reference Kinoshita Y, Kawanami C, Kishi K, et al. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41:452–8.PubMedPubMedCentralCrossRef Kinoshita Y, Kawanami C, Kishi K, et al. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41:452–8.PubMedPubMedCentralCrossRef
Metadata
Title
Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation
Authors
Chihiro Takeuchi
Junichi Sato
Nobutake Yamamichi
Natsuko Kageyama-Yahara
Akiko Sasaki
Takemi Akahane
Rika Aoki
Shigemi Nakajima
Masayoshi Ito
Mitsue Yamamichi
Yu-Yu Liu
Nobuyuki Sakuma
Yu Takahashi
Yoshiki Sakaguchi
Yosuke Tsuji
Kouhei Sakurai
Shuta Tomida
Keiko Niimi
Toshikazu Ushijima
Mitsuhiro Fujishiro
Publication date
14-11-2023
Publisher
Springer Nature Singapore
Keyword
Gastritis
Published in
Journal of Gastroenterology / Issue 2/2024
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-023-02055-x

Other articles of this Issue 2/2024

Journal of Gastroenterology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.